DePuy hip system moves toward European market debut — 4 details

Johnson & Johnson’s DePuy Synthes received the European CE Mark for its Bi-Mentum Dual Mobility System used in hip surgeries, according to Med-Tech Innovation.

Advertisement

What you should know:

1. Intended for use in patients with a higher risk of dislocation, the Bi-Mentum system features a standard femoral head articulating within a large polyethylene liner, which swivels inside a metal shell.

2. Bi-Mentum is already available in the U.S. It is expected to make its debut in European markets in April.

3. DePuy’s dual-mobility acetabular cups have been implanted in 165,000 cases since 2007.

4. The rate of instability caused by dislocation after total hip arthroplasty is as high as 7 percent in the primary setting and 25 percent in the revision setting. Surgically treating a dislocation after THA can increase hip replacement costs by 342 percent.

More articles on devices:
3 things to know about orthopedic surgeon salary & 4 other must-read articles
US ASC market to hit $84.1B by 2027
The No. 1 opportunity for ASC growth: 3 insights from Dr. Philip Schneider

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.